The increased integrin alphavbeta3 immunolabeling at the ultrastructural level was quantified in primary breast cancer cells vs. normal ones, performing Western immunoblotting for the integrin beta3 subunit. The gene discussed is ITGAV; the disease is breast carcinoma.